The IRB national Reliance agreement has been signed and operational involving 5 institutions currently. (Hamd Medical Corporation, Weill Cornell Medicine – Qatar, Primary Health Care Corporation, Sidra Medicine, Qatar Biobank). There are three potential national reliance agreement partners expected to join soon. (Qatar University, Qatar Biomedical Research Institute, and Aspetar.)
CTU is officially a part of the WIN consortium. The WIN Consortium is a collaboration aimed at advancing personalized cancer medicine. It brings together academia, biotech, and pharma to share resources and accelerate innovative therapies for better patient outcomes.
